Authors
Latest:
Going “retro”: A perspective on robotic retroperitoneal renal surgeryImprovements in technology have renewed interest in the technique.
Latest:
Management of hormone-naïve oligometastatic prostate cancerGrowing evidence supports the existence of an intermediate metastatic disease state.
Latest:
The Future of Prostate Cancer ImagingProstate cancer experts highlight some closing thoughts and exciting research in progress on prostate cancer imaging.
Latest:
Key Takeaways on Evolving Bladder Cancer Treatment LandscapeThe expert panel concludes its discussion by providing key takeaways on the evolving bladder cancer treatment landscape following ESMO 2023.
Latest:
Juan J. Andino, MD, on how urologists can get involved in health advocacy“There's state advocacy work groups and other public policy work groups where folks can remain involved and keep pushing to improve the delivery of health care,” says Juan J. Andino, MD, MBA.
Latest:
Expert shares best practices to improve patient collectionsImproving your patient payment process in 2023 is important to maintain a positive relationship with your patients and with your practice’s bottom line.
Latest:
Tools urologists need to thrive in a value-based worldPractices must embark on a journey that goes beyond new technology.
Latest:
Prednisone may improve total motile count post vasectomy reversalA course of treatment with prednisone may offer improvement in mean total motile count for men who undergo vasectomy reversal and subsequently have partial or complete anastomotic obstruction, according to a recent study.
Latest:
One-tenth of sperm retrievals performed by gynecologistsA recent study is questioning some of the current trends in sperm retrieval practices in private U.S. clinics that treat infertile couples.
Latest:
Study: Many post-op ER visits preventableAbout half of postoperative visits to emergency rooms following urologic surgery could be prevented, but simply improving patient education may not significantly reduce the number of these visits, researchers say.
Latest:
Treatment options for high-volume mCNPCDaniel P. Petrylak, MD, leads the discussion on approaching treatment of high-volume metastatic castration-naïve prostate cancer.
Latest:
Transitional Zone sampling can be spared in some men with suspicious prostate cancer lesions on mpMRI“This zone-dependent biopsy strategy warrants prospective evaluation to optimize the extent of systematic biopsies in presence of suspicious mpMRI lesions,” the authors wrote.
Latest:
Gender disparities in bladder cancer managementPoor outcomes in women may stem from diagnostic, therapeutic, and biologic factors.
Latest:
Low-Grade, Intermediate-Risk NMIBC: The Hidden LesionPanelists discuss how UGN-102, a reverse thermal hydrogel formulation of mitomycin, offers an FDA-approved ablative treatment option for patients with intermediate-risk non-muscle invasive bladder cancer (NMIBC), demonstrating 80% complete response rates in the ENVISION trial (NCT05243550) and allowing for the de-escalation of surveillance and reduced surgical burden.
Latest:
Urologist shares advice on maintaining a healthy screen-life balance"The mental toll of excessive screen time is a pressing concern in health care," writes Neil Baum, MD.
Latest:
Key Takeaways on the Evolving NMIBC Treatment LandscapeThe panel concludes by offering key takeaways on the evolving treatment landscape for BCG-unresponsive non–muscle invasive bladder cancer.
Latest:
Expert discusses differentiating prostate cancer from age-related issuesA significant challenge lies in differentiating prostate cancer symptoms from common age-related issues.
Latest:
FDA grants priority review to PSMA PET imaging agent 18F-DCFPyL for prostate cancerThe new drug application for 18F-DCFPyL is supported by results from the OSPREY and CONDOR trials.
Latest:
Transgender education exposure lowFew urology residents receive didactic education on gender-affirming care, survey shows.
Latest:
Streamlined management of Peyronie’s diseaseIn this article, we describe our thought processes in treating patients with Peyronie's disease, which are summarized in an algorithm.
Latest:
Streamlined management of Peyronie’s diseaseIn this article, we describe our thought processes in treating patients with Peyronie's disease, which are summarized in an algorithm.
Latest:
Streamlined management of Peyronie’s diseaseIn this article, we describe our thought processes in treating patients with Peyronie's disease, which are summarized in an algorithm.
Latest:
Role of blue light cystoscopy to detect bladder cancer"Numerous clinical studies have exhibited significantly improved tumor detection rates with BLC," write Zachary L. Smith, MD, and Norm D. Smith, MD.
Latest:
Role of blue light cystoscopy to detect bladder cancer"Numerous clinical studies have exhibited significantly improved tumor detection rates with BLC," write Zachary L. Smith, MD, and Norm D. Smith, MD.
Latest:
Does increased stress lead to heart attack?In this edition of Men’s Health Mythbuster, Matthew Pollard, MD, Jesse N. Mills, MD look at what impact stress really has on the cardiovascular system.
Latest:
Letters: Hypoactive desire disorder a 'true' conditionIn this month's Letters to the Editor, one reader responds to an article on testosterone therapy in women and another looks to address urology's work force shortage.
Latest:
Does increased stress lead to heart attack?In this edition of Men’s Health Mythbuster, Matthew Pollard, MD, Jesse N. Mills, MD look at what impact stress really has on the cardiovascular system.
Latest:
Letters: Hypoactive desire disorder a 'true' conditionIn this month's Letters to the Editor, one reader responds to an article on testosterone therapy in women and another looks to address urology's work force shortage.
Latest:
Data bolster case for surveillance in men with low-grade, low-risk localized prostate cancer"This study demonstrates that for up to 10 years after diagnosis, approximately 50% of men with low-risk prostate cancer can safely remain on AS, without cancer progression or treatment, since less than 1% died of prostate cancer," writes Badar M. Mian, MD.
